This page is the continuation of patient information in support of Section 6A
PATIENT INFORMATION
Alberts WM. (2007). Introduction: Diagnosis and Management of Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest 132(3), 20S-22S. (Retrieved 19th Feb 2015): http://journal.publications.chestnet.org/article.aspx?articleID=1211602
Conklin, C.M., Craddock, K.J., Have, C., Laskin, J., Couture, C. & Ionescu, D.N. Immunohistochemistry is a reliable screening tool for identification of ALK rearrangement in non-small-cell lung carcinoma and is antibody dependent. J. Thorac. Oncol. 8, 45–51 (2013). (Retrieved 19th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed/23196275?dopt=Abstract&holding=npg
Ellis PM, Blais N, Soulieres D et al. (2011). A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancer. J Thorac Oncol. 6(8):1379-91. (Retrieved 19th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed?term=21709590
Gould MK, Donington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143(5)(suppl):e93S-e120S. (Retrieved 19th Feb 2015): http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749714/
Grossi F. Management of non-small cell lung in cancer patients with stable disease. Drugs. 2012; 72 Suppl 1:20-27. (Retrieved 19th Feb 2015): http://link.springer.com/article/10.2165%2F1163013-S0-000000000-00000
Lewis SZ, Diekemper R, Addrizzo-Harris DJ. (2013). Methodology for development of guidelines for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5), 41S-50S. (Retrieved 19th Feb 2015): http://journal.publications.chestnet.org/article.aspx?articleid=1685829
Mukhopadhyay S, Katzenstein AL. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Am. J. Surg. Pathol.35,15–25 (2011). (Retrieved 19th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed/21164283
Ost DE, Yeung SC, Tanoue LT, Gould MK. (2013). Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5 Suppl),e121S-41S. (Retrieved 19th Feb 2015): http://journal.publications.chestnet.org/article.aspx?articleid=1685288
Papanicolaou Society of Cytopathology Task Force on Standards of Practice (1999). Guidelines of the Papanicolaou Society of Cytopathology for the Examination of Cytologic Specimens Obtained from the Respiratory Tract. Diagnostic Cytopathology, 21(1). 61-69. http://papsociety.org/guidelines/respiratorytract.pdf
Rivera MP, Mehta AC, Wahidi MM. (2013). Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5 Suppl), e142S. (Retrieved 19th Feb 2015): http://journal.publications.chestnet.org/article.aspx?articleid=1685797
Schwartz AM, Rezaei MK. (2013). Diagnostic surgical pathology in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 143(5 Suppl), e251S-62S. (Retrieved 29th Jan 2015): http://journal.publications.chestnet.org/article.aspx?articleid=1685831
Solis L, Behrens C, Gabriela Raso M et al. (2012). Histologic Patterns and Molecular Characteristics of Lung Adenocarcinma Associated with Clinical Outcome. Cancer 118(11), 2889-2899. (Retrieved 19th Feb 2015): http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369269/
Terry IJ, Leung S, Laskin J et al. (2010). Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples. Am. J. Surg. Pathol.34(12),1805–1811. (Retrieved 19th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed/21107086
Travis WD, Colby TV, Corrin B, et al.: Histological typing of lung and pleural tumours. 3rd ed. Berlin: Springer-Verlag, 1999.
Travis, WD, Brambilla, E, Muller-Hermlink, HK, Harris, CC (eds). World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC Press. Lyon 2004.
Travis WD, Rekhtman N, Riley GJ, et al. (2010). Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift. J Thorac Oncol. 5(4), 411. (Retrieved 19th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed?term=20357614
Travis WD, Brambilla E, Van Schil P, et al. (2011). Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification. Eur Respir J 38(2), 239-43. (Retrieved 19th Feb 2015): http://erj.ersjournals.com/content/38/2/239.long
Travis WD, Brambilla E, Riely GJ. (2013). New pathologic classification of lung cancer: relevance for clinical practice and clinical trials. J Clin Oncol 31(8), 992-1001. (Retrieved 19th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed?term=23401443
Travis, WD, Brambilla E, Noguchi M et al. (2013). Diagnosis of Lung Cancer in Small Biopsies and Cytology. Implications of the 2011 International Association for the Study of Lung Cancer/ American Thoracic Society/European Respiratory Society Classification. Arch Pathol Lab Med 137, 668–684. (Retrieved 19th Feb 2015): https://www.ncbi.nlm.nih.gov/pubmed/22970842
WHO Classification of Tumors of the Lung. 3rd Edition. (Retrieved 10th Feb 2015): http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-chap1.pdf
